搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
News Medical
8 分钟
Mandatory calorie labels boost awareness but fail to reduce intake
Mandatory calorie labeling in England's out-of-home food sector did not significantly reduce calories purchased or consumed, ...
1 小时
New asthma treatment 'gamechanger' for treating serious attacks
Scientists say this is the first new way of treating the attacks in 50 years despite 3.8 million deaths across the world ...
3 小时
Alector: Bleak Prospects After Alzheimer's Failure
Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...
4 小时
First treatment in 50 years for serious asthma attacks is ‘game-changer’
Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...
4 小时
First asthma treatment in 50 years found to tackle deadly attacks could be 'game changer'
Scientists discover benralizumab could tackle suffocating attacks for people with both asthma and chronic obstructive ...
Science Daily
5 小时
Drug research: Decoding the structure of nano 'gene ferries'
Researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs.
8 小时
Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET
Acadia is on track to achieve over $1 billion in annualized sales in 2025. The next phase of growth could come from two ...
9 小时
Decoding the structure of nano 'gene ferries' to advance RNA drugs
LMU researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs.
News Medical
10 小时
New insights into cationic polymer structure in RNA drug delivery
LMU researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs.
clinicaltrialsarena
11 小时
Outlook Therapeutics stock craters as wet AMD drug fails Phase III trial
The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava ...
T-Net
12 小时
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
Lexaria Bioscience Corp., a global innovator in drug delivery platforms announced that dosing has been completed for human pilot study #3 investigating a DehydraTECH-processed version of the dual ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈